论文部分内容阅读
目的观察前列腺增生腔内治疗方法——经尿道双极等离子前列腺腔内剜除法的临床疗效。方法对124例前列腺增生患者行经尿道双极等离子前列腺腔内剜除法,观察手术时间,术中出血量,术后留置导尿管时间,术后并发症,比较手术前后的国际前列腺症状评分(International Prostate Symptom Score,IPSS)、生活质量(quality of life,QOL)评分、残余尿量(residual urine volume,RUV)、最大尿流率(Qmax)的差异。结果手术时间30～90min,平均(40±10)min;术中出血量(80±10)ml;术后留置导尿管时间(4±0.5)d;全部患者随访6～12个月,IPSS由(28.8±2.3)分下降到(8.6±2.6)、QOL由(4.5±0.5)减少至(1.5±0.5);剩余尿量由(130±5)ml下降到(10±4)ml;Qmax由(7.0±2.5)ml/s上升至(18±2.3)ml/s。所有病例随访6～12个月。结论经尿道双极等离子前列腺腔内剜除法切除组织彻底,出血少,并发症少,技术可行,疗效确定。
Objective To observe the clinical efficacy of transurethral bipolar plasma prostatectomy in the treatment of benign prostatic hyperplasia. Methods One hundred and twenty-four patients with benign prostatic hyperplasia underwent transurethral bipolar plasma prostatectomy. The operation time, intraoperative blood loss, postoperative catheterization time and postoperative complications were observed. The international Prostate Symptom Score Prostate Symptom Score (IPSS), quality of life (QOL) score, residual urine volume (RUV) and maximum flow rate (Qmax). Results The operation time was 30-90 minutes, with an average of (40 ± 10) min; the blood loss during operation was (80 ± 10) ml; the duration of indwelling catheterization was (4 ± 0.5) d. All the patients were followed up for 6-12 months. The QOL decreased from (4.5 ± 0.5) to (1.5 ± 0.5) and the remaining urine volume decreased from (130 ± 5) ml to (10 ± 4) ml from (28.8 ± 2.3) to (8.6 ± 2.6) From (7.0 ± 2.5) ml / s to (18 ± 2.3) ml / s. All cases were followed up for 6 to 12 months. Conclusion Transurethral bipolar plasma prostate resection of the prostate tissue removal, less bleeding, fewer complications, technical feasibility, efficacy determined.